Anti-retroviral effects of type I IFN subtypes in vivo (Q28585391)

interferon alpha-6

1 reference

interferon alpha 9

1 reference

interferon alpha 1

1 reference

7

Ulf Dittmer

1 reference

31 January 2017

Nicole Gerlach

1

1 reference

31 January 2017

Kathrin Gibbert

2

1 reference

31 January 2017

Christina Alter

3

1 reference

31 January 2017

Savita Nair

4

1 reference

31 January 2017

Gennadiy Zelinskyy

5

1 reference

31 January 2017

Cassandra M. James

European Journal of Immunology

6

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

31 January 2017

1 reference

31 January 2017

39

1 reference

31 January 2017

136–146

1 reference

31 January 2017

1

1 reference

31 January 2017

Characterization of a mouse interferon gene locus I. Isolation of a cluster of four alpha interferon genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Localization of the mouse interferon-beta 1 gene to chromosome 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Characterization of the murine alpha interferon gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Organization, structure and expression of murine interferon alpha genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Interferon--a major regulator of natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Type I interferons (alpha/beta) in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Effects of type I interferons on Friend retrovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Interferon alpha for the treatment of advanced renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Antiviral treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

The human interferon alpha species and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Virus free, cell-based assay for the quantification of murine type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Role of natural killer cells in resistance against friend retrovirus-induced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Plasmacytoid dendritic cells: the key to CpG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Immunoprotective determinants in friend murine leukemia virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

Human type I interferons differ greatly in their effects on the proliferation of primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Differing T-cell requirements for recombinant retrovirus vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021

Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838311

7 January 2021